Erek Nelson

MD, MS
Surgical Oncology

Cancers Treated:

Adrenal Anal Breast Carcinoid Colon Colorectal Esophageal Gallbladder & Bile Duct Liver Melanoma Mesothelioma Neuroendocrine Tumors Pancreatic Rectum Sarcoma Skin Stomach Thyroid Parathyroid

Specializing In:

Robotic oncologic surgery

About Erek Nelson

Biography:

Dr. Nelson is a Fellow in the Complex General Surgical Oncology program. Having completed General Surgery Residency in 2022 at the Mayo Clinic in Rochester, MN, he specializes in the minimally invasive treatment of GI malignancies using the robotic platform. He is heavily involved in medical education, and his research interests include immunodeficient large animal models of human malignancy. 

Positions

Roswell Park Comprehensive Cancer Center
  • Fellow
  • Complex General Surgical Oncology
  • Department of Surgical Oncology

Background

Education and Training:

  • 2011-2015 - MD - Boston University School of Medicine, Boston, MA
  • 2010-2011 - MS - Human Nutrition, Columbia University, New York, NY

Residency:

  • 2015-2022 - General Surgery Residency, Mayo Clinic, Rochester, MN

Professional Memberships:

  • Society of Surgical Oncology
  • International Liver Transplant Society
  • Americas Hernia Society
  • American College of Surgeons
  • Alpha Omega Alpha

Honors & Awards:

  • 2020 - Best Clinical Paper, Society of Surgical Oncology
  • 2018 - Best Clinical Paper, Minnesota Surgical Society

Publications

Functional characterization of a bioengineered liver after heterotopic implantation in pigs. Anderson BD, Nelson ED, Joo D, Amiot BP, Katane AA, Mendenhall A, Steiner BG, Stumbras AR, Nelson VL, Palumbo RN, Gilbert TW, Davidow DS, Ross JJ, Nyberg SL. Commun Biol. 2021 Oct 7;4(1):1157. doi: 10.1038/s42003-021-02665-2. PMID: 34620986; PMCID: PMC8497596.

Limited Expansion of Human Hepatocytes in FAH/RAG2-Deficient Swine. Nelson ED, Larson E, Joo DJ, Mao S, Glorioso J, Abu Rmilah A, Zhou W, Jia Y, Mounajjed T, Shi M, Bois M, Wood A, Jin F, Whitworth K, Wells K, Spate A, Samuel M, Minshew A, Walters E, Rinaldo P, Lillegard J, Johnson A, Amiot B, Hickey R, Prather R, Platt JL, Nyberg SL. Tissue Eng Part A. 2021 Jul 26. doi: 10.1089/ten.TEA.2021.0057. Epub ahead of print. PMID: 34309416.

Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigs. Shaheen MF, Joo DJ, Ross JJ, Anderson BD, Chen HS, Huebert RC, Li Y, Amiot B, Young A, Zlochiver V, Nelson E, Mounajjed T, Dietz AB, Michalak G, Steiner BG, Davidow DS, Paradise CR, van Wijnen AJ, Shah VH, Liu M, Nyberg SL. Nat Biomed Eng. 2020 Apr;4(4):437-445. doi: 10.1038/s41551-019-0460-x. Epub 2019 Oct 14. Erratum in: Nat Biomed Eng. 2019 Nov 5;: PMID: 31611679; PMCID: PMC7153989.

Autologous Adipose Tissue-Derived Mesenchymal Stem Cells Introduced by Biliary Stents or Local Immersion in Porcine Bile Duct Anastomoses. Zhang Y, Sharma A, Joo DJ, Nelson E, AbuRmilah A, Amiot BP, Boyer CJ, Alexander JS, Jalan-Sakrikar N, Martin J, Moreira R, Chowdhury SA, Smart M, Dietz AB, Nyberg SL, Heimbach JK, Huebert RC. Liver Transpl. 2020 Jan;26(1):100- 112. doi: 10.1002/lt.25682. PMID: 31742878; PMCID: PMC7061488.

Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production. Larson EL, Joo DJ, Nelson ED, Amiot BP, Aravalli RN, Nyberg SL. Stem Cell Reports. Stem Cell Reports. 2021 Oct 12:S2213-6711(21)00495-1. doi: 10.1016/j.stemcr.2021.09.018. Epub ahead of print. PMID: 34678209.